ATE303131T1 - Zusammensetzungen zur nasalen verabreichung - Google Patents
Zusammensetzungen zur nasalen verabreichungInfo
- Publication number
- ATE303131T1 ATE303131T1 AT98955814T AT98955814T ATE303131T1 AT E303131 T1 ATE303131 T1 AT E303131T1 AT 98955814 T AT98955814 T AT 98955814T AT 98955814 T AT98955814 T AT 98955814T AT E303131 T1 ATE303131 T1 AT E303131T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- nasal administration
- nasal
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9725519.4A GB9725519D0 (en) | 1997-12-02 | 1997-12-02 | Nasal formulation |
GBGB9805253.3A GB9805253D0 (en) | 1998-03-13 | 1998-03-13 | Nasal formulation |
PCT/GB1998/003572 WO1999027905A1 (en) | 1997-12-02 | 1998-11-27 | Compositions for nasal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE303131T1 true ATE303131T1 (de) | 2005-09-15 |
Family
ID=26312701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98955814T ATE303131T1 (de) | 1997-12-02 | 1998-11-27 | Zusammensetzungen zur nasalen verabreichung |
Country Status (13)
Country | Link |
---|---|
US (2) | US6342251B1 (de) |
EP (1) | EP1035833B1 (de) |
JP (2) | JP4754067B2 (de) |
AR (1) | AR017694A1 (de) |
AT (1) | ATE303131T1 (de) |
AU (1) | AU751182B2 (de) |
CA (1) | CA2312839C (de) |
DE (1) | DE69831421T2 (de) |
DK (1) | DK1035833T3 (de) |
ES (1) | ES2249846T3 (de) |
NO (1) | NO329381B1 (de) |
NZ (1) | NZ504786A (de) |
WO (1) | WO1999027905A1 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566368B2 (en) * | 1994-04-22 | 2003-05-20 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
US7022683B1 (en) | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
US6200591B1 (en) | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
DE19834506A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Transmucosales therapeutisches System zur Anwendung von Sildenafil |
DE19834507A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil |
US20020002175A1 (en) * | 2000-09-19 | 2002-01-03 | Charanjit Behl | Nasal delivery of apomorphine in combination with glycol derivatives |
US6436950B1 (en) | 1998-08-14 | 2002-08-20 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of apomorphine |
WO2000059491A2 (en) * | 1999-04-06 | 2000-10-12 | Zonagen, Inc. | Methods for modulating the human sexual response |
US6632419B2 (en) * | 1999-05-04 | 2003-10-14 | Aradigm Corporation | Increasing libido in humans via acute testosterone administration |
US7258850B2 (en) * | 1999-05-04 | 2007-08-21 | Aradigm Corporation | Methods and compositions for treating erectile dysfunction |
BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
CZ20023637A3 (cs) | 2000-04-07 | 2003-02-12 | Tap Pharmaceutical Products, Inc. | Deriváty apomorfinu a způsoby jejich použití |
WO2001089543A2 (en) * | 2000-05-26 | 2001-11-29 | Horphag Research Limited | Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion |
US6777000B2 (en) * | 2001-02-28 | 2004-08-17 | Carrington Laboratories, Inc. | In-situ gel formation of pectin |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
DE60223037T2 (de) | 2001-08-16 | 2008-07-24 | Cmp Therapeutics Ltd. | Chitin-mikropartikel und ihre medizinische verwendung |
US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
AU2003234090A1 (en) * | 2002-04-11 | 2003-10-27 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for pulmonary administration |
WO2003086443A1 (en) * | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
CA2487712A1 (en) * | 2002-06-28 | 2004-01-08 | Nastech Pharmaceutical Company Inc. | Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
GB0304636D0 (en) * | 2003-02-28 | 2003-04-02 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition for nasal delivery |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
CA2522231A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
EP1620732A2 (de) * | 2003-04-30 | 2006-02-01 | Nastech Pharmaceutical Company Inc. | Unterexpression von claudin als marker von tumor-metastasen |
US20050090518A1 (en) * | 2003-10-24 | 2005-04-28 | Nastech Pharmaceutical Company Inc. | Method for treating parkinson's disease using apomorphine and apomorphine prodrugs |
US20050129679A1 (en) * | 2003-12-15 | 2005-06-16 | Nastech Pharmaceutical Company Inc. | Method for opening tight junctions |
US7297786B2 (en) | 2004-07-09 | 2007-11-20 | University Of Iowa Research Foundation | RNA interference in respiratory epitheial cells |
US20070110788A1 (en) * | 2005-11-14 | 2007-05-17 | Hissong James B | Injectable formulation capable of forming a drug-releasing device |
WO2008020318A2 (en) * | 2006-03-30 | 2008-02-21 | Engene, Inc. | Non-viral compositions and methods for transfecting gut cells in vivo |
TW201414506A (zh) | 2006-04-21 | 2014-04-16 | Toko Yakuhin Kogyo Kk | 噴灑用凝膠型皮膚及/或黏膜附著型製劑及使用該製劑之投藥系統 |
GB2437488A (en) * | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
US7959943B2 (en) * | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
US7976873B2 (en) * | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
WO2009040595A1 (en) * | 2007-09-28 | 2009-04-02 | Wockhardt Research Centre | Multi-dose pharmaceutical composition of analgesic for nasal administration |
GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
EP2057982A1 (de) * | 2007-11-09 | 2009-05-13 | Archimedes Development Limited | Intranasale Zusammensetzungen |
US9198997B2 (en) | 2008-04-24 | 2015-12-01 | Medtronic, Inc. | Rehydratable thiolated polysaccharide particles and sponge |
WO2009132228A1 (en) | 2008-04-24 | 2009-10-29 | Medtronic, Inc. | Chitosan-containing protective composition |
CA2721986C (en) | 2008-04-24 | 2017-03-14 | Medtronic, Inc. | Rehydratable polysaccharide particles and sponge |
WO2009132227A1 (en) * | 2008-04-24 | 2009-10-29 | Medtronic, Inc. | Protective gel based on chitosan and oxidized polysaccharide |
RU2513142C2 (ru) | 2008-06-12 | 2014-04-20 | Медтроник Ксомед Инк. | Способ лечения хронических ран |
EP2346324A4 (de) | 2008-10-06 | 2012-10-10 | Microbial Defense Systems Llc | Antimikrobielle zusammensetzung sowie verfahren zu ihrer herstellung und verwendung |
CZ302789B6 (cs) | 2009-11-25 | 2011-11-09 | Zentiva, K. S. | Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva |
AU2012253476B2 (en) | 2011-05-10 | 2015-09-24 | Next Science IP Holdings Pty Ltd | Antimicrobial solid and methods of making and using same |
DK3024474T3 (da) | 2013-07-23 | 2022-03-28 | Serenity Pharmaceuticals Llc | Sammensætninger omfattende desmopressin i kombination med en beta-3-adrenoreceptor-agonist |
CN106233141B (zh) | 2014-02-18 | 2018-08-21 | 罗伯特·I·汉金 | 用于诊断和治疗味觉或嗅觉的损失和/或失真的方法和组合物 |
KR20170097045A (ko) * | 2014-11-20 | 2017-08-25 | 알레간 인코포레이티드 | 알파-아드레날린성 수용체 길항제와 조합된 데스모프레신을 포함하는 방법 및 조성물 |
FR3032618A1 (fr) * | 2015-02-12 | 2016-08-19 | Laboratoires Chemineau | Composition a base de plantes de la famille des malvaceae pour une administration dans la cavite nasale |
EP3056219B1 (de) * | 2015-02-12 | 2018-08-22 | Laboratoires Chemineau | Zusammensetzung auf pflanzenbasis der familie der malvengewächse (malvaceae) zur verabreichung auf schleimhäuten |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
WO2023133463A1 (en) * | 2022-01-06 | 2023-07-13 | Cyrano Therapeutics, Inc. | Improved nasal administration of parkinson's therapeutics |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62123112A (ja) | 1985-11-22 | 1987-06-04 | Sunstar Inc | 軟膏基剤 |
DE3601132A1 (de) | 1986-01-16 | 1987-07-23 | Christian Bannert | Verfahren zur behandlung der schleimhaut |
JPS62236862A (ja) | 1986-04-09 | 1987-10-16 | Nippon Kayaku Co Ltd | 人工粘液 |
JPH01501708A (ja) * | 1987-01-08 | 1989-06-15 | ナステツク フアーマスーテイカル カンパニー,インコーポレイテツド | アミノ酸の経鼻投与 |
US4826683A (en) * | 1987-01-09 | 1989-05-02 | Bates Harry L | Decongestant |
FR2614021B1 (fr) * | 1987-04-14 | 1991-03-01 | Andre Buzas | Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant |
US4915948A (en) | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
DE3827561C1 (de) | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
US5707644A (en) * | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
JPH0436233A (ja) * | 1990-05-29 | 1992-02-06 | Biomaterial Universe Kk | 生理活性物質含有生体内分解吸収性の徐放性製剤 |
JPH0597706A (ja) | 1991-04-09 | 1993-04-20 | Chemex Block Drug Jv | アフタ性潰瘍および他の粘膜皮膚障害の処置方法 |
IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
ATE241984T1 (de) * | 1993-03-26 | 2003-06-15 | Franciscus Wilhelmus He Merkus | Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin |
JP3204510B2 (ja) * | 1993-04-05 | 2001-09-04 | コンペティティブ テクノロジーズ,インク. | 勃起不全の診断および治療 |
HU225496B1 (en) * | 1993-04-07 | 2007-01-29 | Scios Inc | Pharmaceutical compositions of prolonged delivery, containing peptides |
GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
BR9407397A (pt) * | 1993-07-12 | 1996-11-05 | Virus Res Inst | Vacinas microencapsuladas em hidrogel |
JP3696265B2 (ja) * | 1994-02-04 | 2005-09-14 | 日本オルガノン株式会社 | 点鼻液剤 |
ATE189121T1 (de) * | 1994-04-22 | 2000-02-15 | Pentech Pharmaceuticals Inc | Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion |
GB9414966D0 (en) * | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
GB9707934D0 (en) * | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
-
1998
- 1998-11-27 DE DE69831421T patent/DE69831421T2/de not_active Expired - Lifetime
- 1998-11-27 WO PCT/GB1998/003572 patent/WO1999027905A1/en active IP Right Grant
- 1998-11-27 EP EP98955814A patent/EP1035833B1/de not_active Expired - Lifetime
- 1998-11-27 JP JP2000522892A patent/JP4754067B2/ja not_active Expired - Fee Related
- 1998-11-27 DK DK98955814T patent/DK1035833T3/da active
- 1998-11-27 AU AU12535/99A patent/AU751182B2/en not_active Ceased
- 1998-11-27 AT AT98955814T patent/ATE303131T1/de active
- 1998-11-27 ES ES98955814T patent/ES2249846T3/es not_active Expired - Lifetime
- 1998-11-27 CA CA002312839A patent/CA2312839C/en not_active Expired - Fee Related
- 1998-11-27 AR ARP980106027A patent/AR017694A1/es unknown
- 1998-11-27 NZ NZ504786A patent/NZ504786A/en not_active IP Right Cessation
-
2000
- 2000-06-02 US US09/586,139 patent/US6342251B1/en not_active Expired - Lifetime
- 2000-06-02 NO NO20002851A patent/NO329381B1/no not_active IP Right Cessation
-
2001
- 2001-08-01 US US09/920,698 patent/US20010046519A1/en not_active Abandoned
-
2010
- 2010-10-07 JP JP2010227620A patent/JP2011026341A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2312839C (en) | 2008-01-15 |
AU751182B2 (en) | 2002-08-08 |
EP1035833B1 (de) | 2005-08-31 |
NZ504786A (en) | 2005-07-29 |
US6342251B1 (en) | 2002-01-29 |
ES2249846T3 (es) | 2006-04-01 |
JP4754067B2 (ja) | 2011-08-24 |
NO20002851D0 (no) | 2000-06-02 |
DK1035833T3 (da) | 2006-01-09 |
AU1253599A (en) | 1999-06-16 |
US20010046519A1 (en) | 2001-11-29 |
NO20002851L (no) | 2000-06-02 |
DE69831421T2 (de) | 2006-06-22 |
WO1999027905A1 (en) | 1999-06-10 |
CA2312839A1 (en) | 1999-06-10 |
EP1035833A1 (de) | 2000-09-20 |
JP2001524509A (ja) | 2001-12-04 |
DE69831421D1 (de) | 2005-10-06 |
NO329381B1 (no) | 2010-10-04 |
JP2011026341A (ja) | 2011-02-10 |
AR017694A1 (es) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE303131T1 (de) | Zusammensetzungen zur nasalen verabreichung | |
NO20005913D0 (no) | Legemiddelsammensetning | |
ID27415A (id) | Komposisi farmaseutik | |
ID22891A (id) | Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan | |
DE69738333D1 (de) | Nichtpolare Spray zur bukkalen Verabreichung | |
EA199900373A3 (ru) | Фармацевтические композиции | |
DE69833286D1 (de) | Inhalationsgerät | |
IS5487A (is) | Innúðatæki | |
DK0920302T4 (da) | Farmaceutisk aerosolsammensætning | |
ID18352A (id) | Komposisi-komposisi farmasi | |
ID29262A (id) | Komposisi farmasi | |
DE69822172D1 (de) | Levosimendanhaltige oral anzuwendende arzneizusammensetzungen | |
DE69816736D1 (de) | Nasale Inhaliervorrichtung | |
ID27201A (id) | Komposisi farmasi | |
IS2515B (is) | Lyfjasamsetningar | |
EE200000330A (et) | Farmatseutilised kompositsioonid | |
PT941100E (pt) | Composicoes farmaceuticas | |
DE69824327D1 (de) | Inhalationsgerät | |
ID26215A (id) | Komposisi farmasi | |
NO994436L (no) | Farmasöytiske sammensetninger | |
DE29701214U1 (de) | Spurenelementpräparate zur oralen Verabreichung | |
BR1100755A (pt) | composição farmacêutica | |
BR1101089A (pt) | Composição terapêutica de uso nasal | |
SE9400371D0 (sv) | Compositions for inhalation | |
DE29703380U1 (de) | Multivitaminpräparat zur oralen Verabreichung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1035833 Country of ref document: EP |